DKSH has signed an agreement to acquire Medipharm Sdn Bhd, a leading distributor of pharmaceutical and medical devices in Brunei, enhancing its market presence in the Asia-Pacific region.
Information on the Target
DKSH has signed an agreement to acquire Medipharm Sdn Bhd, a prominent distributor of pharmaceutical and medical devices in Brunei. This acquisition aligns with DKSH Healthcare's strategic initiative to expand its presence in the Asia-Pacific region.
Established in 1998, Medipharm has been a key player in the distribution of pharmaceutical products, medical devices, consumer health items, personal care, and nutritional products. The company generates annual net sales exceeding CHF 30 million and has built a solid reputation by serving well-known blue-chip clients, including hospitals, medical centers, clinics, opticians, and pharmacies.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Brunei
The pharmaceutical and medical device industry in Brunei has seen steady growth, fueled by an increasing demand for healthcare services and an enhanced focus on improving public h
Similar Deals
Bambu Ventures → Lemonaid Health
2026
DKSH
invested in
Medipharm Sdn Bhd
in 2024
in a Buyout deal
Disclosed details
Revenue: $20M